CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
62.97
-1.43 (-2.22%)
Jan 28, 2026, 4:00 PM EST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $60.46 billion as of January 29, 2026. Its market cap has decreased by -27.36% in one year.
Market Cap
60.46B
Enterprise Value
72.63B
Revenue
15.56B
Ranking
n/a
PE Ratio
20.14
Stock Price
$62.97
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 60.46B, an increase of 26,168.73%. That is a compound annual growth rate of 19.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 60.73B | 9.37% |
| Dec 31, 2025 | 55.52B | -34.20% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 463.33M |
| CytoDyn | 320.10M |
| Silence Therapeutics | 256.48M |
| Vaxart | 157.22M |
| HST Global | 131.71M |
| BioStem Technologies | 109.82M |
| Nuo Therapeutics | 76.77M |
| Arch Biopartners | 60.99M |